Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Ta...(f the views expressed accuratelyreflect ...)

Date:8/29/2007

f the views expressed accurately reflect his personal views about any and all of the subject securities or issuers discussed; and 2) no part of the research analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed by the research analyst; 3) the analyst responsible for preparing this research report receives compensation based upon various factors, including total revenues of Dawson James and its affiliates, a portion of which is generated by investment banking activities and 4) the analyst and/or members of their immediate family do not own stock in the companies mentioned.

Contact:

Dawson James Securities

John M. Putnam, 561-208-2950

Fax: 561-391-5757

Dawson James Securities is a member of the National Association of Securities Dealers, CRD number 130645.

'/>"/>

SOURCE Dawson James Securities Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related biology technology :

1. Germantown drug company hires pharma veteran James Davidson as COO
2. State puts up $1 million for James Thomsons new stem cell startup
3. OpGen adds Thomas Pyle and James Ogle to board of directors
4. UW stem-cell team led by James Thomson gets $1.25M private grant
5. James Thomson plans to stay in Madison to study genesis of stem cells
6. Early Stage, Step 9: Raising capital in the securities landscape
7. Securities compliance is part of raising capital
8. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
9. Quantitation of the Protein MIA as a Marker for Chondrocytes in Research Samples
10. Control Your siRNA Research
11. Getting Started with MicroRNA Research